Related Experiment Video
Updated: Apr 1, 2026

A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023
APOE Isoforms Control Pathogenic Subretinal Inflammation in Age-Related Macular Degeneration
Olivier Levy1, Sophie Lavalette1, Shulong J Hu1
1Institut National de la Santé et de la Recherche Médicale, U 968, Paris, F-75012, France, Sorbonne Universités, Université Pierre et Marie Curie Paris 06, Unité Mixte de Recherche S 968, Institut de la Vision, Paris, F-75012, France, CNRS, Unité Mixte de Recherche 7210, Paris, F-75012, France.
Abstract:
Contrary to Alzheimer's disease (AD), the APOE2 allele increases and the APOE4 allele reduces the risk to develop age-related macular degeneration (AMD) compared with the most common APOE3 allele. The underlying mechanism for this association with AMD and the reason for the puzzling difference with AD are unknown. We previously demonstrated that pathogenic subretinal mononuclear phagocytes (MPs) accumulate in Cx3cr1-deficient mice due to the overexpression of APOE, interleukin-6, and CC chemokine ligand 2 (CCL2). We here show using targeted replacement mice expressing the human APOE isoforms (TRE2, TRE3, and TRE4) that MPs of TRE2 mice express increased levels of APOE, interleukin-6, and CCL2 and develop subretinal MP accumulation, photoreceptor degeneration, and exaggerated choroidal neovascularization similar to AMD. Pharmacological inhibition of the cytokine induction inhibited the pathogenic subretinal inflammation. In the context of APOE-dependent subretinal inflammation in Cx3cr1(GFP/GFP) mice, the APOE4 allele led to diminished APOE and CCL2 levels and protected Cx3cr1(GFP/GFP) mice against harmful subretinal MP accumulation observed in Cx3cr1(GFP/GFP)TRE3 mice. Our study shows that pathogenic subretinal inflammation is APOE isoform-dependent and provides the rationale for the previously unexplained implication of the APOE2 isoform as a risk factor and the APOE4 isoform as a protective factor in AMD pathogenesis.
Significance Statement:
The understanding of how genetic predisposing factors, which play a major role in age-related macular degeneration (AMD), participate in its pathogenesis is an important clue to decipher the pathomechanism and develop efficient therapies. In this study, we used transgenic, targeted replacement mice that carry the three human APOE isoform-defining sequences at the mouse APOE chromosomal location and express the human APOE isoforms. Our study is the first to show how APOE2 provokes and APOE4 inhibits the cardinal AMD features, inflammation, degeneration, and exaggerated neovascularization. Our findings reflect the clinical association of the genetic predisposition that was recently confirmed in a major pooled analysis. They emphasize the role of APOE in inflammation and inflammation in AMD.
Insights
The APOE2 gene variant increases age-related macular degeneration (AMD) risk, while APOE4 protects against it. This study reveals APOE isoform-dependent inflammation drives AMD pathogenesis, explaining clinical observations.
Area of Science:
- Ophthalmology
- Genetics
- Immunology
Background:
- The apolipoprotein E (APOE) gene influences risk for Alzheimer's disease (AD) and age-related macular degeneration (AMD) differently.
- APOE2 increases AMD risk, while APOE4 decreases it, a contrast to AD, with underlying mechanisms unknown.
Purpose of the Study:
- To investigate the role of APOE isoforms in the pathogenesis of age-related macular degeneration (AMD).
- To elucidate the mechanism behind APOE2's risk and APOE4's protective effects in AMD.
Main Methods:
- Utilized targeted replacement mice expressing human APOE isoforms (TRE2, TRE3, TRE4).
- Analyzed subretinal mononuclear phagocyte (MP) accumulation, photoreceptor degeneration, and choroidal neovascularization.
- Investigated the impact of pharmacological inhibition of cytokine induction.
Main Results:
- TRE2 mice showed increased subretinal MP accumulation, photoreceptor degeneration, and exaggerated choroidal neovascularization, mimicking AMD.
- APOE4 expression diminished APOE and CCL2 levels, protecting against MP accumulation in a mouse model.
- Inhibition of cytokine induction reduced pathogenic subretinal inflammation.
Conclusions:
- Pathogenic subretinal inflammation in AMD is dependent on APOE isoforms.
- APOE2 acts as a risk factor, while APOE4 acts as a protective factor in AMD pathogenesis.
- Findings provide a rationale for the differential clinical associations of APOE isoforms with AMD.

